Insight and Industry: On the dynamics of technological change in Medicine Cambridge

Compositions containing either poly( epsilon -caprolactone) or copolymers of epsilon -caprolactone with other lactones, together with a drug, when subdermally implanted in the body, provide a slow sustained release of the drug. The polymers may be designed to biodegrade during or subsequent to the depletion of the drug.